Molecular markers in uterine serous cancer: Correlation between endometrial biopsy and hysterectomy specimensElizabeth Lokich(Women & Infants Hospital of Rhode Island), Cara Mathews(Brown University)Gynecologic Oncology ReportsApril 25, 201910.1016/j.gore.2019.04.005Cited by 6SaveCiteExport RISWatch citationsRelated PapersSafety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study|Clinical Cancer Research|2023|80517O Overall survival (OS) at 7-year (y) follow-up (f/u) in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) who received maintenance olaparib in the SOLO1/GOG-3004 trial|Annals of Oncology|2022|6